Cargando…
LLT1-CD161 Interaction in Cancer: Promises and Challenges
The success of immune checkpoint therapy in cancer has changed our way of thinking, promoting the design of future cancer treatments that places the immune system at the center stage. The knowledge gained on immune regulation and tolerance helped the identification of promising new clinical immune t...
Autores principales: | Braud, Veronique M., Meghraoui-Kheddar, Aïda, Elaldi, Roxane, Petti, Luciana, Germain, Claire, Anjuère, Fabienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854185/ https://www.ncbi.nlm.nih.gov/pubmed/35185935 http://dx.doi.org/10.3389/fimmu.2022.847576 |
Ejemplares similares
-
High Dimensional Imaging Mass Cytometry Panel to Visualize the Tumor Immune Microenvironment Contexture
por: Elaldi, Roxane, et al.
Publicado: (2021) -
Autofluorescence identifies highly phagocytic tissue-resident macrophages in mouse and human skin and cutaneous squamous cell carcinoma
por: Bourdely, Pierre, et al.
Publicado: (2022) -
SARS-CoV-2 infection impairs NK cell functions via activation of the LLT1-CD161 axis
por: Lenart, Marzena, et al.
Publicado: (2023) -
LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation
por: Llibre, Alba, et al.
Publicado: (2016) -
Revising CX3CR1 Expression on Murine Classical and Non-classical Monocytes
por: Meghraoui-Kheddar, Aïda, et al.
Publicado: (2020)